Researchers
Vučićević, Katarina
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2024 | Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies (✓) | Škorić, Biljana; Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2024 | The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients | Magro, Fernando; ...; Vucicevic, Katarina M ![]() ![]() | Article | 21M21 |
2024 | Integrating Clopidogrel’s First-Pass Effect in a Joint Semi-Physiological Population Pharmacokinetic Model of the Drug and Its Inactive Carboxylic Acid Metabolite | Pejčić, Zorica; Topić Vučenović, Valentina; Miljković, Branislava ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct Dosing | Milaković, Dragana; Kovačević, Tijana; Kovačević, Peđa; Barišić, Vedrana; Avram, Sanja; Dragić, Saša; Zlojutro, Biljana; Momčičević, Danica; Miljković, Branislava ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study | Kovačević, Peđa; Milaković, Dragana; Kovačević, Tijana; Barišić, Vedrana; Dragić, Saša; Zlojutro, Biljana; Miljković, Branislava ![]() ![]() ![]() ![]() | Article | 22M22 |
2023 | Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma (✓) | Skoric, Biljana; Kuzmanovic, Milos B; Jovanovic, Marija N; Miljkovic, Branislava R ![]() ![]() ![]() ![]() | Article | 23M23 |
2023 | Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s disease | Homšek, Ana ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Lidocaine Clearance as Pharmacokinetic Parameter of Metabolic Hepatic Activity in Patients with Impaired Liver | Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2023 | Association of clozapine and norclozapine levels with patient and therapy characteristics—focus on interaction with valproic acid (✓) | Panić, Bojana; Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2023 | Farmakometrijski modeli – savremen alat za kvantifikaciju varijabilnosti i individualizaciju režima doziranja lekova | Vučićević, Katarina ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology (✓) | Homšek, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2023 | Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria (✓) | Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2023 | Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients | Marković, Srđan; Kralj, Đorđe; Odanović, Olga; Homšek, Ana ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Modelling fatigue events in prostate cancer patients on radiotherapy (✓) | Roganović, Maša ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Farmakokinetika (✓) | Pokrajac, Milena ![]() ![]() ![]() ![]() ![]() | Text book | Mp. category will be shown later |
2023 | Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab (✓) | Homšek Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2022 | Učestalost primene benzodiazepina kod starijih pacijenata u primarnoj zdravstvenoj zaštiti | Kovačević, Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Pregled terapije i terapijskih problema kod pacijenata sa astmom u primarnoj zdravstvenoj zaštiti | Lazarević, Katarina; Kovačević, Milena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Populacioni farmakokinetički model takrolimusa kod pacijenata sa transplantiranom jetrom | Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2022 | Assessment of concentrations and normalized concentrations of variability in methotrexate concentrations between cycles | Škorić, Biljana; Jovanović, Marija ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |